Janson Pharmaceuticals incurred the following costs in 2018
related to a new cancer drug:
Research for new formulas | $ | 2,485,000 | |
Development of a new formula | 1,660,000 | ||
Legal and filing fees for a patent for the new formula | 66,000 | ||
Total | $ | 4,211,000 | |
The development costs were incurred after technological and
commercial feasibility was established and after the future
economic benefits were deemed probable. The project was
successfully completed and the new drug was patented before the end
of the 2018 fiscal year.
Required:
1. Calculate the amount of research and
development expense Janson should report in its 2018 income
statement related to this project.
2. Calculate the amount of research and
development expense Janson should report in its 2018 income
statement related to this project. Assuming that Janson prepares
its financial statements according to International Financial
Reporting Standards.
Answer:
1. We have,
According to US G.A.A.P, Janson report the following cases
Particulars | Amount($) |
Research for new formula | 2,485,000 |
Development of a new formula | 1,660,000 |
Total | 4,145,000 |
Here Legal fees will be capitalized as intangible assests.
Therefore,Janson report the resarch and developmnet expense in its 2018 income statement is $4145000
2) We have,
According to (IFRS) International Financial Reporting Standards,
Research and development expense consider only the Research for new formula in given problem that is $2485000.
The remaining two costs are used for development of a new formula
Here also Legal fee will be used as intangible assests.
Get Answers For Free
Most questions answered within 1 hours.